Results 91 to 100 of about 53,476 (305)
Osteoprotegerin And MTHFR Gene Variations In Rheumatoid Arthritis: Association With Disease Susceptibility And Markers of Subclinical Atherosclerosis [PDF]
, 2021 Aikaterini Arida +4 more
openalex +1 more source
Rare Metals, EarlyView.ABSTRACT Periodontitis is a chronic infectious oral disease triggered by periodontopathogenic bacteria, resulting in the progressive inflammation and destruction of the tissues surrounding teeth. To achieve reprogramming of the infectious microenvironment for periodontitis therapy, a nanoformulation was proposed by loading polydopamine (PDA) with ...
Hao Liang +14 more
wiley +1 more source
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL*
Journal of Biological Chemistry, 1998 TRAIL is a tumor necrosis factor-related ligand that induces apoptosis upon binding to its death domain-containing receptors, DR4 and DR5. Two additional TRAIL receptors, TRID/DcR1 and DcR2, lack functional death domains and function as decoy receptors ...
J. Emery +14 more
semanticscholar +1 more source
Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism [PDF]
European Journal of Endocrinology, 1999 The integrity of the skeleton depends upon bone remodeling, the permanent and controlled resorption of bone by osteoclasts (OC) and its subsequent replacement by bone-forming osteoblasts. An imbalance between bone resorption and bone formation results in osteoporosis (if bone resorption exceeds bone formation) or osteopetrosis (if bone formation ...
openaire +2 more sources
VIEW, EarlyView.PIEZO1 is highly correlated with mechanical stimulation, controlling bone growth and remodeling, while showing specific distribution characteristics under distinct loads. Upon dialectical review, this manuscript proposes that PIEZO1 could serve as a target for osteoporosis and a quantitative indicator for monitoring bone health in real‐time.
Chunyu Zhang, Yuehong Wang
wiley +1 more source
Frontiers in Pharmacology, 2019 The ratio of osteoprotegerin (OPG) to the receptor activator of NF-κB ligand (RANKL) is a key determinant in the regulation of bone metabolism. The study was performed to screen novel anti-osteoporotic drugs regulating OPG/RANKL ratio and evaluate their ...
Xiaowan Han +9 more
doaj +1 more source
Alterations of bone proteins in medication‐related osteonecrosis of the jaw
European Journal of Oral Sciences, Volume 133, Issue 2, April 2025.Abstract Changes in the protein expression pattern of osteoblastic lineage cells from the alveolar bone (OLAB) during medication‐related osteonecrosis of the jaw (MRONJ) have rarely been investigated. This lack of information is partly because of the limited availability of healthy samples and the lack of human alveolar bone cell lines for research ...
Andrea Schubert +6 more
wiley +1 more source
Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism [PDF]
, 2018 Aim of the study was to evaluate the micro and macro-vascular changes in patients with primary hyperparathyroidism (PHPT) compared to controls. 30 postmenopausal PHPT women (15 hypertensive and 15 normotensive) and 30 normotensive controls underwent ...
Biamonte, Federica +8 more
core +2 more sources
Study The Association between Serum Osteoprotegerin and Diabetic Kidney Disease [PDF]
, 2022 Mohamed A. Elbana +3 more
openalex +1 more source
LGR4 (GPR48): The Emerging Inter-Bridge in Osteoimmunology
BiomedicinesLeucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4), a member of the G-protein-coupled receptor (GPCR) family, has been implicated in various regulatory functions across multiple differentiation stages and numerous target sites in bone ...
Wonbong Lim
doaj +1 more source